We are live on ! Find out more
YIA

YHB Investment Advisors Portfolio holdings

AUM $1.56B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+27.39%
3 Year Est. Return
+85.72%
5 Year Est. Return
+104.16%
10 Year Est. Return
+409.93%
AUM
$587M
AUM Growth
+$27.7M
Cap. Flow
-$4.57M
Cap. Flow %
-0.78%
Top 10 Hldgs %
27.99%
Holding
189
New
13
Increased
69
Reduced
65
Closed
2

Top Buys

Rank Stock Value
1
TRIP icon
TripAdvisor
TRIP
+$1.26M
2
CELG
Celgene Corp
CELG
+$878K
3
PFE icon
Pfizer
PFE
+$588K
4
ING icon
ING
ING
+$549K
5
AER icon
AerCap
AER
+$547K

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$2.92M
2
MDLZ icon
Mondelez International
MDLZ
+$2.67M
3
PEP icon
PepsiCo
PEP
+$1.61M
4
GE icon
GE Aerospace
GE
+$1.6M
5
PG icon
Procter & Gamble
PG
+$1.29M

Sector Composition

Rank Sector Weight
1 Healthcare 18.86%
2 Financials 16.89%
3 Technology 15.56%
4 Consumer Discretionary 10.67%
5 Communication Services 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDX icon
151
FedEx
FDX
$74.4B
$353K 0.06%
+1,415
New +$324K
ILG
152
DELISTED
ILG, Inc Common Stock
ILG
$350K 0.06%
12,284
-1
-0% -$29
NSC icon
153
Norfolk Southern
NSC
$76.4B
$333K 0.06%
2,300
+455
+25% +$61.1K
AGN
154
DELISTED
Allergan plc
AGN
$321K 0.05%
1,961
-940
-32% -$169K
VLO icon
155
Valero Energy
VLO
$89.1B
$319K 0.05%
3,476
MO icon
156
Altria Group
MO
$114B
$309K 0.05%
4,334
-100
-2% -$6.7K
DFS
157
DELISTED
Discover Financial Services
DFS
$305K 0.05%
3,970
LNC icon
158
Lincoln National
LNC
$8.96B
$304K 0.05%
3,950
-50
-1% -$3.78K
BXP icon
159
Boston Properties
BXP
$11.2B
$297K 0.05%
2,283
-400
-15% -$50.2K
POST icon
160
Post Holdings
POST
$4.1B
$296K 0.05%
5,699
-77
-1% -$4.1K
XRAY icon
161
Dentsply Sirona
XRAY
$2.85B
$292K 0.05%
4,441
-158
-3% -$10K
SWKS icon
162
Skyworks Solutions
SWKS
$9.89B
$291K 0.05%
3,070
-50
-2% -$5.21K
EPD icon
163
Enterprise Products Partners
EPD
$82.3B
$283K 0.05%
10,686
-80
-0.7% -$2.03K
FISV
164
Fiserv Inc
FISV
$29.1B
$279K 0.05%
4,258
ELV icon
165
Elevance Health
ELV
$82.7B
$273K 0.05%
1,214
+81
+7% +$17.3K
ES icon
166
Eversource Energy
ES
$27.3B
$266K 0.05%
4,205
+60
+1% +$3.79K
BIIB icon
167
Biogen
BIIB
$30.6B
$263K 0.04%
827
-70
-8% -$22.5K
CI icon
168
Cigna
CI
$72.8B
$256K 0.04%
1,262
HIG icon
169
Hartford Financial Services
HIG
$39B
$254K 0.04%
4,505
-200
-4% -$11.2K
CSX icon
170
CSX Corp
CSX
$93.6B
$251K 0.04%
13,686
WBS icon
171
Webster Financial
WBS
$12.7B
$250K 0.04%
4,448
-240
-5% -$13.1K
PBCT
172
DELISTED
People's United Financial Inc
PBCT
$250K 0.04%
13,386
-3,000
-18% -$55.6K
TER icon
173
Teradyne
TER
$63.7B
$239K 0.04%
5,720
MD icon
174
Pediatrix Medical
MD
$2.06B
$235K 0.04%
+4,390
New +$207K
CAT icon
175
Caterpillar
CAT
$407B
$229K 0.04%
+1,452
New +$201K

Similar funds

YHB Investment Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, YHB Investment Advisors held 189 positions worth $587M, up 5% from $559M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

YHB Investment Advisors's Q4 2017 filing shows 13 new, 69 increased, 65 reduced and 2 closed positions. Its largest new stake was TripAdvisor: 34,860 shares worth $1.2M. The largest sale was Monsanto Co, an estimated $2.92M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Financials and Technology.

  • YHB Investment Advisors's largest Q4 2017 buy was TripAdvisor: 34,860 shares worth $1.2M.
  • YHB Investment Advisors added most to Celgene Corp in Q4 2017, an estimated $878K increase.
  • YHB Investment Advisors's biggest Q4 2017 reduction was Monsanto Co, cutting an estimated $2.92M.
  • YHB Investment Advisors fully exited Boston Scientific in Q4 2017, selling an estimated $263K.
  • YHB Investment Advisors's ten largest holdings make up 28% of its $587M portfolio in Q4 2017.
  • YHB Investment Advisors opened 13 new positions and closed 2 in Q4 2017.
  • YHB Investment Advisors's portfolio value rose 5% quarter-over-quarter to $587M.

Based on YHB Investment Advisors's 13F filing for Q4 2017, filed 16 Jan 2018.